Big Data on Financial Reports of Big Pharma

Big Pharma Quarterly report

Big Pharma Annual report

Big Pharma Assets

abbvie (NYSE: ABBV)

AbbVie Inc.
Industry: Biopharmaceutical

$ABBV Quarterly report

$ABBV Annual report

$ABBV Assets

Abbott (NYSE: ABT)

ABBOTT LABORATORIES
Industry: Health care, Medical devices, Pharmaceutical

Period	Opening price	Closing price	Growth rate	Report date
2023Q3	95.450	114.000	19.43%	2023-10-18

$ABT Quarterly report

$ABT Annual report

$ABT Assets

AMGEN (NASDAQ: AMGN)

Amgen Inc. (formerly Applied Molecular Genetics Inc.)
AMGEN INC
Industry: Biotechnology

$AMGN Quarterly report

$AMGN Annual report

$AMGN Assets

AstraZeneca (NASDAQ: AZN)

AstraZeneca PLC (AZ)
ASTRAZENECA PLC
United Kingdom
Industry: Pharmaceutical, Biotechnology

Period	Opening price	Closing price	Growth rate	Report date
2024Q4	73.145	69.930	-4.40%	2025-02-06
2024Q3	63.435	70.935	11.82%	2024-11-12
2024Q2	76.140	64.790	-14.91%	2024-07-25
2024Q1	74.990	79.710	6.29%	2024-04-25
2023Q4	61.035	71.200	16.65%	2024-02-08

$AZN Quarterly report

$AZN Annual report

$AZN Assets

Bristol Myers Squibb (NYSE: BMY)

BRISTOL-MYERS SQUIBB COMPANY, doing business as Bristol Myers Squibb (BMS)
BRISTOL MYERS SQUIBB CO
Industry: Pharmaceuticals

$BMY Quarterly report

$BMY Annual report

$BMY Assets

GILEAD (NASDAQ: GILD)

GILEAD SCIENCES, INC.
Industry: Pharmaceutics, Biotechnology

  Some rounding errors in the BS, IS, SOCF have been corrected.

Period	Opening price	Closing price	Growth rate	Report date
2023Q3	80.320	76.710	-4.49%	2023-11-07

$GILD Quarterly report

$GILD Annual report

$GILD Assets

Johnson&Johnson (NYSE: JNJ)

Johnson & Johnson (J&J)
JOHNSON & JOHNSON
Industry: Pharmaceutical, Medical Technology
  Fiscal year end: December 31

$JNJ Quarterly report

$JNJ Annual report

$JNJ Assets

Lilly (NYSE: LLY)

ELI LILLY AND COMPANY
ELI LILLY & Co
Industry: Pharmaceutical

Period	Opening price	Closing price	Growth rate	Report date
2024Q2	873.700	903.580	3.42%	2024-08-08
2023Q3	575.900	704.900	22.40%	2023-11-02
2023Q2	504.870	554.460	9.82%	2023-08-08

$LLY Quarterly report

$LLY Annual report

$LLY Assets

MERCK (NYSE: MRK)

Merck & Co., Inc.
Industry: Pharmaceutical

Period	Opening price	Closing price	Growth rate	Report date
2023Q3	102.330	120.780	18.03%	2023-10-26

$MRK Quarterly report

$MRK Annual report

$MRK Assets

novo nordisk (NYSE: NVO)

NOVO NORDISK A/S
NOVO NORDISK A S
Denmark
Industry: Pharmaceuticals, Health care
 Financial data: DKK
  Market cap: USD

Period	Opening price	Closing price	Growth rate	Report date
2024Q4	85.331	66.290	-22.31%	2025-02-05
2024Q3	108.270	82.620	-23.69%	2024-11-06
2023Q3	101.280	109.020	7.64	2023-11-02
2023Q1	161.540	187.590	16.13%	2023-05-04

$NVO Quarterly report

$NVO Annual report

$NVO Assets

NOVARTIS (NYSE: NVS)

Novartis AG
NOVARTIS AG
Switzerland
Industry: Pharmaceuticals

$NVS Quarterly report

$NVS Annual report

$NVS Assets

Pfizer (NYSE: PFE)

PFIZER INC.
PFIZER INC
Industry: Pharmaceutical, Biotechnology

  Some rounding errors in the BS, IS, SOCF have been corrected.

$PFE Quarterly report

$PFE Annual report

$PFE Assets

REGENERON (NASDAQ: REGN)

REGENERON PHARMACEUTICALS, INC.
Industry: Pharmaceuticals, Biotech

Period	Opening price	Closing price	Growth rate	Report date
2023Q4	970.230	903.480	-6.88%	2024-02-02

$REGN Quarterly report

$REGN Annual report

$REGN Assets

VERTEX (NASDAQ: VRTX)

Vertex Pharmaceuticals Incorporated
VERTEX PHARMACEUTICALS INC / MA
Industry: Pharmaceuticals, Biotherapeutics

Period	Opening price	Closing price	Growth rate	Report date
2024Q4	459.830	500.190	8.78%	2025-02-11
2024Q3	483.000	469.970	-2.70%	2024-11-05

$VRTX Quarterly report

$VRTX Annual report

$VRTX Assets